Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
NANot yet recruitingINTERVENTIONAL
Enrollment
2,100
Participants
Timeline
Start Date
October 15, 2025
Primary Completion Date
October 15, 2029
Study Completion Date
October 15, 2030
Conditions
Coronary Artery Disease
Interventions
DEVICE
ihtDEStiny® DES implanted
ihtDEStiny® DES implanted
DEVICE
Xience™ DES implanted
Xience™ DES implanted
All Listed Sponsors
lead
Fundación EPIC
OTHER
NCT07190690 - Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions | Biotech Hunter | Biotech Hunter